Zacks Company Profile for Kymera Therapeutics, Inc. (KYMR : NSDQ) |
|
|
|
Company Description |
Kymera Therapeutics Inc. is a biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics for degrade dysregulated, disease-causing proteins to address previously intractable disease targets. Kymera Therapeutics Inc. is based in Watertown, United States.
Number of Employees: 188 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $43.64 |
Daily Weekly Monthly
 |
20 Day Moving Average: 1,055,018 shares |
Shares Outstanding: 65.12 (millions) |
Market Capitalization: $2,841.82 (millions) |
Beta: 2.18 |
52 Week High: $53.27 |
52 Week Low: $19.45 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
1.18% |
-3.20% |
12 Week |
98.27% |
61.76% |
Year To Date |
8.48% |
2.82% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Nello Mainolfi - Chief Executive Officer and President
Bruce Booth - Chair of the Board of Directors
Bruce Jacobs - Chief Financial Officer
Felix Baker - Director
Jeff Albers - Director
|
|
Peer Information
Kymera Therapeutics, Inc. (CORR.)
Kymera Therapeutics, Inc. (RSPI)
Kymera Therapeutics, Inc. (CGXP)
Kymera Therapeutics, Inc. (BGEN)
Kymera Therapeutics, Inc. (GTBP)
Kymera Therapeutics, Inc. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 501575104
SIC: 2836
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
|
|
Share - Related Items
Shares Outstanding: 65.12
Most Recent Split Date: (:1)
Beta: 2.18
Market Capitalization: $2,841.82 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $-0.79 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-3.35 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 14.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/06/25 |
|
|
|
|